Javascript must be enabled to continue!
A Randomized Clinical Trial of Vision Therapy/Orthoptics versus Pencil Pushups for the Treatment of Convergence Insufficiency in Young Adults
View through CrossRef
ABSTRACT:
Purpose.
The purpose of this article is to compare vision therapy/orthoptics, pencil pushups, and placebo vision therapy/orthoptics as treatments for symptomatic convergence insufficiency in adults 19 to 30 years of age.
Methods.
In a randomized, multicenter clinical trial, 46 adults 19 to 30 years of age with symptomatic convergence insufficiency were randomly assigned to receive 12 weeks of office‐based vision therapy/orthoptics, office‐based placebo vision therapy/orthoptics, or home‐based pencil pushups. The primary outcome measure was the symptom score on the Convergence Insufficiency Symptom Survey. Secondary outcome measures were the near point of convergence and positive fusional vergence at near.
Results.
Only patients in the vision therapy/orthoptics group demonstrated statistically and clinically significant changes in the near point of convergence (12.8 cm to 5.3 cm, p = 0.002) and positive fusional vergence at near (11.3Δ to 29.7Δ, p = 0.001). Patients in all three treatment arms demonstrated statistically significant improvement in symptoms with 42% in office‐based vision therapy/orthoptics, 31% in office‐based placebo vision therapy/orthoptics, and 20% in home‐based pencil pushups achieving a score <21 (our predetermined criteria for elimination of symptoms) at the 12‐week visit.
Discussion.
In this study, vision therapy/orthoptics was the only treatment that produced clinically significant improvements in the near point of convergence and positive fusional vergence. However, over half of the patients in this group (58%) were still symptomatic at the end of treatment, although their symptoms were significantly reduced. All three groups demonstrated statistically significant changes in symptoms with 42% in office‐based vision therapy/orthoptics, 31% in office‐based placebo vision therapy/orthoptics, and 20% in home‐based pencil push‐ups meeting our criteria for elimination of symptoms.
Title: A Randomized Clinical Trial of Vision Therapy/Orthoptics versus Pencil Pushups for the Treatment of Convergence Insufficiency in Young Adults
Description:
ABSTRACT:
Purpose.
The purpose of this article is to compare vision therapy/orthoptics, pencil pushups, and placebo vision therapy/orthoptics as treatments for symptomatic convergence insufficiency in adults 19 to 30 years of age.
Methods.
In a randomized, multicenter clinical trial, 46 adults 19 to 30 years of age with symptomatic convergence insufficiency were randomly assigned to receive 12 weeks of office‐based vision therapy/orthoptics, office‐based placebo vision therapy/orthoptics, or home‐based pencil pushups.
The primary outcome measure was the symptom score on the Convergence Insufficiency Symptom Survey.
Secondary outcome measures were the near point of convergence and positive fusional vergence at near.
Results.
Only patients in the vision therapy/orthoptics group demonstrated statistically and clinically significant changes in the near point of convergence (12.
8 cm to 5.
3 cm, p = 0.
002) and positive fusional vergence at near (11.
3Δ to 29.
7Δ, p = 0.
001).
Patients in all three treatment arms demonstrated statistically significant improvement in symptoms with 42% in office‐based vision therapy/orthoptics, 31% in office‐based placebo vision therapy/orthoptics, and 20% in home‐based pencil pushups achieving a score <21 (our predetermined criteria for elimination of symptoms) at the 12‐week visit.
Discussion.
In this study, vision therapy/orthoptics was the only treatment that produced clinically significant improvements in the near point of convergence and positive fusional vergence.
However, over half of the patients in this group (58%) were still symptomatic at the end of treatment, although their symptoms were significantly reduced.
All three groups demonstrated statistically significant changes in symptoms with 42% in office‐based vision therapy/orthoptics, 31% in office‐based placebo vision therapy/orthoptics, and 20% in home‐based pencil push‐ups meeting our criteria for elimination of symptoms.
Related Results
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Młodociani sprawcy przestępstw przeciwko mieniu
Młodociani sprawcy przestępstw przeciwko mieniu
The new Polish penal legislation of 1969 introduced special rules of criminal liability of young adult offenders' aged 17-20. In 1972 criminological research was undertaken in orde...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...

